|
SNX13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.094500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.858300E-02 |
| Normal-vs-Stage2 |
3.846200E-01 |
| Normal-vs-Stage3 |
2.324900E-03 |
| Normal-vs-Stage4 |
1.598370E-03 |
| Stage1-vs-Stage2 |
5.566800E-01 |
| Stage1-vs-Stage3 |
4.274000E-02 |
| Stage1-vs-Stage4 |
5.278300E-02 |
| Stage2-vs-Stage3 |
6.264300E-02 |
| Stage2-vs-Stage4 |
4.694000E-02 |
| Stage3-vs-Stage4 |
7.267400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.145960E-02 |
| Normal-vs-AfricanAmerican |
2.085000E-01 |
| Normal-vs-Asian |
2.218100E-02 |
| Caucasian-vs-AfricanAmerican |
6.604400E-01 |
| Caucasian-vs-Asian |
8.478000E-01 |
| AfricanAmerican-vs-Asian |
5.778400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.897800E-03 |
| Normal-vs-Female |
4.388200E-02 |
| Male-vs-Female |
2.968200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.060800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.018800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.006080E-02 |
| Normal-vs-Age(81-100Yrs) |
2.642200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.045500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.303610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.505000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.249400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.662200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.127800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.031710E-02 |
| Classical-VS-Follicular |
5.789800E-02 |
| Classical-VS-Other |
6.791600E-01 |
| Classical-VS-Normal |
3.262000E-02 |
| Tall-VS-Follicular |
8.006500E-04 |
| Tall-VS-Other |
4.175000E-01 |
| Tall-VS-Normal |
6.013300E-04 |
| Follicular-VS-Other |
3.527800E-01 |
| Follicular-VS-Normal |
6.531600E-01 |
| Other-VS-Normal |
1.835760E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.632300E-02 |
| Normal-vs-N1 |
1.432490E-02 |
| N0-vs-N1 |
3.669800E-01 |
|
|
